General Information of Drug (ID: DMLUZJR)

Drug Name
KTE-C19 CAR-T cell therapy
Indication
Disease Entry ICD 11 Status REF
Mantle cell lymphoma 2A85.5 Phase 2 [1]
Cross-matching ID
TTD ID
D0A4PJ

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)